The Anticonvulsant Zonisamide Inhibits Hydroxyl Radical Generated from Methylguanidine by Noda, Yasuko et al.
M ethylguanidine (MG) is a known nephrotoxin and neurotoxin.  Patients with chronic uremia 
show markedly high plasma levels of MG,  and uremic 
toxicity due to excessive MG levels is a characteristic 
feature in chronic renal failure [1-3].  Mori et al.  [4] 
were the ﬁrst to report that γ-guanidinobutyric acid 
(GGBA) induced convulsions in rabbits.  Other guanid-
ino compounds including MG were subsequently shown 
to induce convulsions in experimental animals [5,6].
　 Guanidino compounds including GGBA,  arginine,  
taurocyamine,  glycocyamine,  and N-acetylarginine are 
normally present at low levels in human brain tissues 
[7].  However,  the accumulation of such compounds in 
uremic patients and in experimental animal models of 
uremia could possibly trigger characteristic convul-
sions [6,8].  Highly elevated levels of guanidino com-
pounds in the brain may also cause metabolic abnor-
malities such as altered neurotransmitter metabolism 
[9],  and the intracisternal injection of these com-
pounds induces convulsions in rats and rabbits 
[10,11].  In addition,  the brains of animal models of 
epilepsy and in amygdala- or hippocampus-kindled rats 
showed sustained increases in MG [12,13].
　 In previous in vitro studies,  we showed that 
extremely high levels of MG and other guanidino com-
pounds such as α-guanidinoglutaric acid (α-GGA) gen-
erate reactive oxygen species (ROS),  i.e.,  hydroxyl 
radicals (•OH),  and superoxide anion radicals (O2•－),  
all of which can damage cell membranes and lead to 
neuronal depolarization,  which in turn may induce 
epileptogenicity [14,15].
　 The anticonvulsant zonisamide (ZNS) scavenges 
•OH [16],  which is the most damaging ROS.  In the 
present study,  we examined the inhibitory eﬀect of 
ZNS on •OH generation by MG by using electron spin 
resonance (ESR) with a spin trap,  5,5ʼ-dimethyl-1- 
pyrroline N-oxide (DMPO).
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Methylguanidine (MG) is a known nephrotoxin and neurotoxin,  and an intracisternal injection of MG 
can induce convulsions in experimental animals.  In this in vitro study,  we examined the inhibitory 
eﬀects of the antiepileptic agent zonisamide (ZNS) on hydroxyl radicals (•OH) generated from MG by 
using an electron spin resonance (ESR) technique.  ZNS scavenged •OH generated from MG in a 
dose-dependent manner through direct scavenging during the auto-oxidation of MG.  The rate constant 
of ZNS reacting with the •OH was at a near diﬀusion-controlled rate.  These ﬁndings indicate that ZNS 
might detoxify MG and could thus protect against convulsive disorders.
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Materials and Methods
　 Chemicals. ZNS (1,2-benzisoxazole-3-methan-
sulfonamide) (C8H8N2O3S: MW 212.23) was obtained 
from Dainippon Sumitomo Pharmaceutical Co. (Osaka,  
Japan).  MG hydrochloride (MW 109.56) was obtained 
from Tokyo Kasei Kogyo Co. (Tokyo).  L-ascorbic acid 
2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyl-
2H-1-benzopyran-6-yl hydrogen phosphate) potassium 
salt (EPC-K1) (MW 706.90),  which we ﬁrst found as a 
standard material for •OH scavenging,  was a kind gift 
from Dr. Kazumi Ogata (Oga Research,  Osaka) [17].  
Diethylenetriaminepentaacetic acid (DETAPAC) was 
purchased from Sigma-Aldrich Chemical Co. (St. Louis,  
MO,  USA),  and the spin trap DMPO was from 
Labotec Co. (Tokyo).  All other chemicals were 
sourced from Wako Pure Chemical Industries (Osaka).
　 Hydroxyl radical (•OH) generation from 
MG. The ESR measurements were performed as 
follows: An exact amount of MG (10 mg; ﬁnal concen-
tration,  0.46 M) was taken to a test tube followed by 
the buﬀer or 0.1  methylcellulose-1500 (MC) in 
de-ionized ultra-pure water (pure water) (30 µl) (for 
the sample solution: EPC-K1 in the buﬀer or ZNS in 
MC; control: without sample),  8.9 M DMPO (20 µl),  
0.1 M Tris buﬀer (pH 6.0,  100 µl),  and 0.2 mM Fe2+-
DETAPAC in pure water (50 µl) (ﬁnal volume,  200 µl).  
The solution of MC and the sample solutions were 
prepared just before analysis.
　 The mixture was quickly mixed using a vortex 
mixer and immediately put into an ESR quartz ﬂat cell 
(capacity,  200 µl).  ESR recordings were started 
immediately after the addition of Fe2+-DETAPAC.  
The generation of •OH was measured as the spin 
adducts of DMPO (DMPO-OH).  The intensity of the 
peak height of the DMPO-OH adducts was normalized 
against the third peak of Mn2+ in an internal standard 
manganese oxide (MnO) ﬁtted to the ESR spectrome-
ter.  The pH of the reaction mixture was double- 
checked after each ESR measurement,  using pH test 
paper.
　 Inhibitory effect of EPC-K1 or ZNS on •OH 
generated from MG. (i) EPC-K1 was dissolved in 
the buﬀer solution just before analysis.  The diluted 
solutions were examined for the scavenging activity of 
•OH generated from MG as described.  (ii) An appro-
priate amount of ZNS was precisely weighed,  and 
added with 0.1  MC solution just before analysis.  The 
ZNS solution was diluted immediately before mea-
surement with 0.1  MC (ZNS ﬁnal concentrations,  
0-30 mM; control: without ZNS),  and the scavenging 
activity of •OH generated from MG was determined as 
described.
　 ESR measurements. ESR spectrometers 
(JES-FA100,  JEOL,  Tokyo) equipped with MnO as 
an internal standard were used.  Basically,  the condi-
tions for the •OH generation from MG were as fol-
lows: microwave frequency,  9.4 GHz; microwave power,  
8 mW; magnetic ﬁeld center,  335.6 mT; sweep width,  
10 mT; modulation width,  0.1 mT; modulation fre-
quency,  100 kHz; response time,  0.1 sec; gain,  1×
500; sweep time,  0.5 min; accumulation,  16 times;  
temperature,  23℃.  The ESR recordings were per-
formed at 16-times accumulation to enhance the inten-
sity of the DMPO-OH signal.
　 In previous experiments [18,19],  the intensity of 
the DMPO-OH signal gradually increased and reached 
a plateau around 8-10 min after the addition of Fe2+,  
and thus the ESR signals were accumulated for 8 min.  
The DMPO-OH signal intensity was almost constant at 
the maximum level in the pH range of 5.5-6.5,  and we 
therefore used pH 6.0 as an optimal experimental con-
dition in this study.
Results
　 Hydroxyl radical (•OH) generation from 
MG. Signals typical of the DMPO-OH adducts 
(peak height ratio 1 : 2 : 2 : 1,  quartet) (Hyperﬁne con-
dition of the DMPO-OH adduct: aN＝1.49 mT,  aHβ＝
1.49 mT) were observed when DMPO was added to 
MG followed by Fe2+-DETAPAC (Fig.  1).  The linear 
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Fig. 1　 Typical DMPO-OH ESR spectra generated from MG.  The 
intensity of the DMPO-OH signal generated from MG (10 mg) (ﬁnal 
concentration in assay,  0.46 M).
relationship was observed between the intensity of the 
DMPO-OH signals and the MG concentrations 
(0-0.92 M) as shown previously [18,19].
　 Inhibitory effect of EPC-K1 on •OH generated 
from MG. EPC-K1,  known as a •OH scavenger,  
suppressed the generation of •OH from MG in a 
dose-dependent manner.  The representative ESR 
spectra for various concentrations of EPC-K1 (ﬁnal 
concentrations,  0,0.085 and 0.42 mM) are shown in 
Fig.  2.  At these concentrations,  EPC-K1 suppressed 
86  and 17  of •OH generation from MG,  respec-
tively.
　 Inhibitory effect of ZNS on •OH generated 
from MG. We dissolved ZNS in 0.1  MC solution 
just before use,  because it hardly dissolved at higher 
concentrations.  ZNS inhibited •OH generated from 
MG in a dose-dependent manner (Fig.  3A,  B),  with an 
ID50 of 18 mM.  The estimated concentration of ZNS 
necessary to completely diminish •OH was 40 mM,  
based on the extension of the dose-response curve.
Discussion
　 EPC-K1 (a phosphate diester of vitamins C and E) 
is a known •OH radical scavenger [17],  and here it 
scavenged •OH generated from MG in a dose-depen-
dent manner,  with an estimated ID50 of 200-250 µM 
under the above-described experimental conditions.  
Unlike other •OH scavengers such as ascorbate,  
EPC-K1 is not thought to act as a reductant,  thus 
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Fig. 2　 Inhibitory eﬀect of EPC-K1 on •OH generated from MG.  
The intensity of DMPO-OH signals generated from MG (ﬁnal con-
centration,  0.46 M) was recorded with or without EPC-K1 (con-
trol:without EPC-K1).
Fig. 3　 Inhibitory eﬀect of ZNS on •OH generated from MG.  (A) A representa-
tive ESR spectrum of DMPO-OH generated from MG (ﬁnal concentration,  
0.46 M) are shown at the various concentrations of ZNS.  The intensity of 
DMPO-OH signals generated from MG (ﬁnal concentration,  0.46 M) was 
recorded with or without ZNS (control: without ZNS).  (B) A representative 
dose-dependent curve for the inhibitory eﬀect of ZNS on •OH generated from MG.
avoiding the possibility of reducing nitroxyl radicals 
or the DMPO-OH adducts,  depending on the condition 
[20,21].
　 ZNS scavenged •OH generated by the Fenton reac-
tion in a dose-dependent manner [16].  In our prelimi-
nary experiments on ZNS,  we observed its direct •OH 
scavenging activity by changing the DMPO concentra-
tions from 0.45 mM to 4.5 mM,  and the value of ID50 
shifted by 10-fold when the concentration of DMPO 
was increased by 10-fold.  Therefore,  ZNS directly 
scavenges •OH when they are encountered,  but does 
not interfere with the •OH generation system itself,  
such as via iron chelating [22].  The reaction rate 
constant k2 in the present study was calculated as 
2.2×109 M－1 s－1 (the reaction rate constant of DMPO 
with •OH,  kDMPO＝3.4×109 M－1 s－1 [23]),  and this 
was also conﬁrmed by the estimation method used in 
our previous studies; i.e.,  in the range of 109－1010 
M－1 s－1 [16],  at near diﬀusion-controlled rates.  The 
values of k2 for some other known •OH scavengers are 
2.7×1010,  3.2×1010,  4.7×109,  3.7×109,  2.7×109,  
and＜7.0×105 M－1 s－1 for melatonin,  salicylate,  
thiourea,  sodium formate,  mannitol,  and urea,  
respectively [23,24].
　 In our previous studies [18,19],  we found that the 
•OH generated from MG was diminished by the addi-
tion of either SOD (200 U/assay) or catalase (650 U/
assay),  eﬀectively suppressed by ethanol (40  and 
70  inhibition for 10  and 20  (v/v) ethanol,  respec-
tively) or dimethylsulfoxide (DMSO) (20  and 40  
inhibition for 20  and 40  (v/v) DMSO,  respec-
tively),  and slightly suppressed by mannitol (20  
inhibition at a concentration of 280 mM),  suggesting 
that MG oxidation may occur via the transient forma-
tion of O2•－ from adjacent oxygen in the medium and 
then H2O2 generation,  followed by the Fenton reaction 
to produce •OH with the existence of iron ions 
[14,15].
　 To examine the hypothesis [14,15] of MG oxida-
tion via the formation of H2O2 followed by the genera-
tion of •OH under the existence of Fe2+,  we measured 
the H2O2.  By using highly sensitive ﬂuorometry 
(detection limit: 0.1 nM),  we detected H2O2 as the 
ﬂuorescence quenching of chromotropic acid (λex＝
440 nm; λex＝235 nm) with a ﬂow technology accord-
ing to the method by Li et al.  [25].  Here we observed 
that the test solution without MG (as a control) showed 
no H2O2,  whereas in the presence of MG,  H2O2 was 
detected in a dose-dependent manner.
　 Pyrogarol [26],  homogentisic acid [27],  and 
6-hydroxyldopamine [28] are examples of agents known 
to non-enzymatically generate ROS via auto-oxidation,  
whereby O2•－ is produced followed by •OH where the 
transition metal exists,  although the underlying mech-
anisms might diﬀer slightly among these agents and 
that of MG.
　 ZNS showed almost no scavenging activity against 
O2•－,  which reacts slowly with most substances and is 
thus less reactive,  whereas ZNS directly scavenged 
•OH generated by the Fenton reaction [16].
　 MG levels increase in serum and urine with chronic 
renal failure in animal models and humans,  and in epi-
leptic foci of brain tissue in animal models [11,29].  
Taking these ﬁndings together with the present 
results,  we speculate that it is possible that ZNS 
contributes,  at least in part,  to suppressing excessive 
ROS generation in the presence of extreme levels of 
MG and particularly •OH,  which is the most hazard-
ous species for damaging biological membranes and 
thus for inducing neuronal depolarization and associ-
ated convulsive seizures.
　 In conclusion,  in this in vitro study,  ZNS inhibited 
•OH generated from MG―which is a known nephro-
toxin and neurotoxin―in a dose-dependent manner,  
and ZNS directly scavenged •OH at near diﬀu-
sion-control rates.  These results suggest that ZNS 
may be beneﬁcial,  at least in part,  for preventing 
MG-related convulsive disorders.
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